Preliminary Study Characterizing the Use of Sitagliptin for Glycemic Control in Healthy Beagle Dogs with Normal Gluco-Homeostasis

Sitagliptin is a dipeptidyl peptidase-4 inhibitor aimed at treating Type 2 diabetes mellitus (T2DM) and T1DM, by increasing blood levels of Glucagon-like peptide 1 (GLP-1) and insulin. The objective of this preliminary study is to characterize Sitagliptin’s ability for glycemic control, in healthy d...

Descripción completa

Detalles Bibliográficos
Autores principales: ODA, Hitomi, MORI, Akihiro, LEE, Peter, SAEKI, Kaori, ARAI, Toshiro, SAKO, Toshinori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Veterinary Science 2014
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221172/
https://www.ncbi.nlm.nih.gov/pubmed/24931645
http://dx.doi.org/10.1292/jvms.13-0590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221172/
https://www.ncbi.nlm.nih.gov/pubmed/24931645
http://dx.doi.org/10.1292/jvms.13-0590

Ejemplares similares